Ferulic acid, a phenolic phytochemical, inhibits UVB-induced matrix metalloproteinases in mouse skin via posttranslational mechanisms

Journal of Nutritional Biochemistry

Volumn 23, Issue 5, 2012, Pages 443-451

  Staniforth, Vanisree ^a   Huang, Wen Ching ^a   Aravindaram, Kandan ^a,b   Yang, Ning Sun ^a  

^a AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^b NATIONAL BUREAU OF PLANT GENETIC RESOURCES   (India)

Author keywords

Cell signaling; Inflammation; Invasion; Matrix metalloproteinase; Proteasome

Indexed keywords

COLLAGEN FIBER; FERULIC ACID; GELATINASE A; GELATINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELASTIC FIBER; ENZYME ACTIVITY; ENZYME INHIBITION; EPIDERMIS HYPERPLASIA; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RADIATION INJURY; RNA TRANSLATION; SKIN INJURY; ULTRAVIOLET B RADIATION;

ANIMALS; CELLS, CULTURED; COUMARIC ACIDS; FEMALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SKIN; ULTRAVIOLET RAYS;

EID: 84859822439     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.01.009     Document Type: Article

References (49)

1. Stamenkovic I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 2003, 200:448-464.
2. Cauwe B., Van den Steen P.E., Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007, 42:113-185.
3. Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006, 11:1696-1701.
4. Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr Pharm Des 2007, 13:333-346.
5. Ullrich S.E. Sunlight and skin cancer: lessons from the immune system. Mol Carcinog 2007, 46:629-633.
6. Wulf H.C., Sandby-Møller J., Kobayasi T., Gniadecki R. Skin aging and natural photoprotection. Micron 2004, 35:185-191.
7. Matsumura Y., Ananthaswamy H.N. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev Mol Med 2002, 4:1-22.
8. Fisher G.J. The pathophysiology of photoaging of the skin. Cutis 2005, 75:5-8.
9. Kahari V.M., Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 1997, 6:199-213.
10. Inomata S., Matsunaga Y., Amano S., Takada K., Kobayashi K., Tsunenaga M., et al. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol 2003, 120:128-134.
11. Dumas V., Kanitakis J., Charvat S., Euvrard S., Faure M., Claudy A. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res 1999, 19:2929-2938.
12. Kricker A., Armstrong B.K., English D.R. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994, 5:367-392.
13. Johnson T., Rowe D.E., Nelson B.R. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992, 26:467-484.
14. Zhang G., Luo X., Sumithran E., Pua V.S., Barnetson R.S., Halliday G.M., et al. Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene 2006, 25:7260-7266.
15. Whiteman D.C., Whiteman C.A., Green A.C. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001, 12:69-82.
16. Hofmann U.B., Westphal J.R., Van Muijen G.N., Ruiter D.J. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000, 115:337-344.
17. Chen S.T., Dou J., Temple R., Agarwal R., Wu K.M., Walker S. New therapies from old medicines. Nat Biotech 2008, 26:1077-1083.
18. Graf E. Antioxidant potential of ferulic acid. Free Radic Biol Med 1992, 13:435-448.
19. Srinivasan M., Sudheer A.R., Menon V.P. Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007, 40:92-100.
20. Barone E., Calabrese V., Mancuso C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontol 2009, 10:97-108.
21. Saija A., Tomaino A., Trombetta D. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int J Pharm 2000, 199:39-47.
22. Lin F.H., Lin J.Y., Gupta R.D., Tournas J.A., Burch J.A., Selim M.A., et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol 2005, 125:826-832.
23. Staniforth V., Chiu L.T., Yang N.S. Caffeic acid suppresses UVB radiation-induced expression of interleukin-10 and activation of mitogen-activated protein kinases in mouse. Carcinogenesis 2006, 27:1803-1811.
24. Zhang D., Bar-Eli M., Meloche S., Brodt P. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J Biol Chem 2004, 279:19683-19690.
25. Jiang Y., Muschel R.J. Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. Cancer Res 2002, 62:1910-1914.
26. Amano S., Ogura Y., Akutsu N., Matsunaga Y., Kadoya K., Adachi E., et al. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process. Br J Dermatol 2005, 2:37-46.
27. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998, 58:1048-1051.
28. Coussens L.M., Tinkle C.L., Hanahan D Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
29. Yan C., Boyd D.D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007, 211:19-26.
30. Fisher G.J., Datta S.C., Talwar H.S., Wang Z.Q., Varani J., Kang S., et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996, 379:335-339.
31. Meeran S.M., Katiyar S., Elmets C.A., Katiyar S.K. Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors. Cancer Res 2007, 67:3785-3793.
32. Gingras A.C., Raught B., Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001, 15:807-826.
33. Liu G., Zhang Y., Bode A.M., Ma W.Y., Dong Z. Phosphorylation of 4E-BP1 is mediated by the p38/MSK1 pathway in response to UVB irradiation. J Biol Chem 2002, 277:8810-8816.
34. Huang C., Li J., Ke Q., Leonard S.S., Jiang B.H., Zhong X.S., et al. Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C. Cancer Res 2002, 62:5689-5697.
35. Nojima H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K., et al. The mammalian target of rapamycin (mTOR) partner, Raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 2003, 278:15461-15464.
36. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998, 8:397-403.
37. Chen B., Ma Y., Meng R., Xiong Z., Zhang C., Chen G., et al. MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals. Acta Biochim Biophys Sin 2010, 42:253-258.
38. Bush K.T., Goldberg A.L., Nigam S.K. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 1997, 272:9086-9092.
39. Park B.K., Zeng X., Glazer R.I. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res 2001, 61:7647-7653.
40. Roos-Mattjus P., Sistonen L. The ubiquitin-proteasome pathway. Ann Med 2004, 36:285-295.
41. Orlowski M., Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys 2003, 415:1-5.
42. Amano S., Akutsu N., Matsunaga Y., Nishiyama T., Champliaud M.F., Burgeson R.E., et al. Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation. Exp Cell Res 2001, 271:249-262.
43. Fisher G.J., Wang Z.Q., Datta S.C., Varani J., Kang S., Voorhees J.J. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997, 337:1419-1428.
44. El-Domyati M., Attia S., Saleh F., Brown D., Birk D.E., Gasparro F., et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol 2002, 11:398-405.
45. Ohnishi Y., Tajima S., Akiyama M., Ishibashi A., Kobayashi R., Horii I. Expression of elastin-related proteins and matrix metalloproteinases in actinic elastosis of sun-damaged skin. Arch Dermatol Res 2000, 292:27-31.
46. El-Abaseri T.B., Putta S., Hansen L.A. Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor. Carcinogenesis 2006, 27:225-231.
47. El-Abaseri T.B., Hansen L.A. EGFR activation and ultraviolet light-induced skin carcinogenesis. J Biomed Biotechnol 2007, 97939.
48. Adiseshaiah P., Vaz M., Machireddy N., Kalvakolanu D.V., Reddy S.P. A Fra-1 dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion. J Cell Physiol 2008, 216:405-412.
49. Sohn Y.T., Oh J.H. Characterization of physicochemical properties of ferulic acid. Arch Pharm Res 2003, 26:1002-1008.